title: OPTN/SRTR 2011 Annual Data Report: liver.
abstract: The current liver allocation system, introduced in 2002, decreased the importance of waiting time for allocation priorities; the number of active wait-listed candidates and median waiting times were immediately reduced. However, the total number of adult wait-listed candidates has increased since 2002, and median waiting time has increased since 2006. Pretransplant mortality rates have been stable, but the number of candidates withdrawn from the list as being too sick to undergo transplant nearly doubled between 2009 and 2011. Deceased donation rates have remained stable, with an increasing proportion of expanded criteria donors. Living donation has decreased over the past 10 years. Transplant outcomes remain robust, with continuously improving graft survival rates for deceased donor, living donor, and donation after circulatory death livers. Numbers of new and prevalent pediatric candidates on the waiting list have decreased. Pediatric pretransplant mortality has decreased, most dramatically for candidates aged less than 1 year. The transplant rate has increased since 2002, and is highest in candidates aged less than 1 year. Graft survival continues to improve for pediatric recipients of deceased donor and living donor livers. Incidence of acute rejections increases with time after transplant. Posttransplant lymphoproliferative disorder remains an important concern in pediatric recipients.
authors.affiliation: Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA.
authors.forename: W R
authors.initials: WR
authors.lastname: Kim
authors.forename: P G
authors.initials: PG
authors.lastname: Stock
authors.forename: J M
authors.initials: JM
authors.lastname: Smith
authors.forename: J K
authors.initials: JK
authors.lastname: Heimbach
authors.forename: M A
authors.initials: MA
authors.lastname: Skeans
authors.forename: E B
authors.initials: EB
authors.lastname: Edwards
authors.forename: A M
authors.initials: AM
authors.lastname: Harper
authors.forename: J J
authors.initials: JJ
authors.lastname: Snyder
authors.forename: A K
authors.initials: AK
authors.lastname: Israni
authors.forename: B L
authors.initials: BL
authors.lastname: Kasiske
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016031:Liver Transplantation; D019520:Living Donors; D014019:Tissue Donors; D014850:Waiting Lists
chemical_list: D007166:Immunosuppressive Agents